CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Technology in Parkinson's disease:challenges and opportunities
Authors
Bastiaan R. Bloem
Paolo Bonato
+27 more
Michelle A. Burack
Jean-Francois Daneault
John M. Dean
E. Ray Dorsey
Bjoern M. Eskofier
Alberto J. Espay
Joe Giuffrida
Catarina Godinho
Jeffery M. Hausdorff
Fay Horak
Malcolm Horne
Anita Kamondi
Jochen Klucken
Lothar Krinke
Ken Kubota
Anthony E. Lang
Max A. Little
Irene Litvan
Walter Maetzler
Aristide Merola
Georgia Mitsi
Movement Disorders Society Task Force on Technology
Fatta B. Nahab
Alice Nieuwboer
Spyros Papapetropoulos
Ralf Reilmann
Tanya Simuni
Publication date
29 April 2016
Publisher
'Wiley'
Doi
View
on
PubMed
Abstract
The miniaturization, sophistication, proliferation, and accessibility of technologies are enabling the capture of more and previously inaccessible phenomena in Parkinson's disease (PD). However, more information has not translated into a greater understanding of disease complexity to satisfy diagnostic and therapeutic needs. Challenges include noncompatible technology platforms, the need for wide-scale and long-term deployment of sensor technology (among vulnerable elderly patients in particular), and the gap between the "big data" acquired with sensitive measurement technologies and their limited clinical application. Major opportunities could be realized if new technologies are developed as part of open-source and/or open-hardware platforms that enable multichannel data capture sensitive to the broad range of motor and nonmotor problems that characterize PD and are adaptable into self-adjusting, individualized treatment delivery systems. The International Parkinson and Movement Disorders Society Task Force on Technology is entrusted to convene engineers, clinicians, researchers, and patients to promote the development of integrated measurement and closed-loop therapeutic systems with high patient adherence that also serve to (1) encourage the adoption of clinico-pathophysiologic phenotyping and early detection of critical disease milestones, (2) enhance the tailoring of symptomatic therapy, (3) improve subgroup targeting of patients for future testing of disease-modifying treatments, and (4) identify objective biomarkers to improve the longitudinal tracking of impairments in clinical care and research. This article summarizes the work carried out by the task force toward identifying challenges and opportunities in the development of technologies with potential for improving the clinical management and the quality of life of individuals with PD. © 2016 International Parkinson and Movement Disorder Society
Similar works
Full text
Open in the Core reader
Download PDF
Available Versions
Aston Publications Explorer
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:publications.aston.ac.uk:2...
Last time updated on 06/03/2017
Crossref
See this paper in CORE
Go to the repository landing page
Download from data provider
info:doi/10.1002%2Fmds.26642
Last time updated on 01/04/2019
Sustaining member
eScholarship - University of California
See this paper in CORE
Go to the repository landing page
Download from data provider
oai:escholarship.org:ark:/1303...
Last time updated on 25/12/2021